The DOI matches its Crossref record; 24 of the 25 references it cites were found in a registry or an index.
p73 is a human p53-related protein that can induce apoptosis
Abstract
The protein p53 is the most frequently mutated tumour suppressor to be identified so far in human cancers. The ability of p53 to inhibit cell growth is due, at least in part, to its ability to bind to specific DNA sequences and activate the transcription of target genes such as that encoding the cell-cycle inhibitor p21Waf1/Cip1 . A gene has recently been identified that is predicted to encode a protein with significant amino-acid sequence similarity to p53. In particular, each of the p53 amino-acid residues implicated in direct sequence-specific DNA binding is conserved in this protein. This gene, called p73, maps to the short arm of chromosome 1, and is found in a region that is frequently deleted in neuroblastomas. Here we show that p73 can, at least when overproduced, activate the transcription of p53-responsive genes and inhibit cell growth in a p53-like manner by inducing apoptosis (programmed cell death).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“p73 is a member of the p53 family of tumor suppressors and has similar transactivation functions relating to the induction of pro-apoptotic genes in response to cellular stress (17, 18).”
From Potentiation of carboplatin-mediated DNA damage by the Mdm2 modulator Nutlin-3a in a humanized orthotopic breast-to-lung metastatic model (2015) · cites this paper as [17]
In the citing paper
“The p53 family member p73α has functions similar to p53 (17, 18, 42, 43), but is regulated differently by Mdm2.”
From Potentiation of carboplatin-mediated DNA damage by the Mdm2 modulator Nutlin-3a in a humanized orthotopic breast-to-lung metastatic model (2015) · cites this paper as [17]
Citations
Cites
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444
A new technique for the assay of infectivity of human adenovirus 5 DNA
Graham, F. L., & van der Eb, A. J. (1973) · Virology · doi:10.1016/0042-6822(73)90341-3 · Cited by 9,302
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
High-Efficiency Transformation of Mammalian Cells by Plasmid DNA
Chen, C., & Okayama, H. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.8.2745 · Cited by 5,327
The p53 tumour suppressor gene
Levine, A. J., Momand, J. A., & Finlay, C. A. (1991) · Nature · doi:10.1038/351453a0 · Cited by 3,785
Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P. (1994) · Science · doi:10.1126/science.8023157 · Cited by 2,559 · cited 1×
“In particular, each of the p53 amino-acid residues implicated in direct sequence-specific DNA binding is conserved in this protei”
BackgroundSuppression of Human Colorectal Carcinoma Cell Growth by Wild-Type p53
Baker, S. J., Markowitz, S. D., Fearon, E. R., Willson, J. K. V., & Vogelstein, B. (1990) · Science · doi:10.1126/science.2144057 · Cited by 1,742
Kaghad, M., Bonnet, H., Yang, A., Créancier, L., Biscan, J.-C., Valent, A., Minty, A. J., Chalon, P., Lélias, J.-M., Dumont, X., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80540-1 · Cited by 1,659
Oncogenic Forms of p53 Inhibit p53-Regulated Gene Expression
Kern, S. E., Pietenpol, J., Thiagalingam, S., Seymour, A., Kinzler, K. W., & Vogelstein, B. (1992) · Science · doi:10.1126/science.1589764 · Cited by 941
Research works printed but not linked: 2
- Kaghad, M. et al. Monoallelically expressed gene related to p53 at the neuroblastoma suppressor-1 locus. Cell (in the press).
- Chen, C. & Okayama, H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7, 2745–2752 (1987). · DOI
Cited by
Sorted by citations
Items 701–800 of 943
p53: The Challenge of Linking Basic Science and Patient Management
Hall, P. A. (1998) · The Oncologist · doi:10.1634/theoncologist.3-4-218 · Cited by 13
Temperature-Sensitive Mutants of p53 Homologs
Pochampally, R. R., Li, C., Lu, W., Chen, L., Luftig, R. B., Lin, J., & Chen, J. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4056 · Cited by 13
Cloning and developmental expression of p73 cDNA in zebrafish
Pan, H., Dung, H.-N., Hsu, H.-M., Hsiao, K., & Chen, L. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01209-9 · Cited by 13
Goldschneider, D., Blanc, É., Raguénez, G., Haddada, H., Bénard, J., & Douc‐Rasy, S. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00089-2 · Cited by 13
Overexpression of p73 causes apoptosis in vascular smooth muscle cells
Davis, B. B., Dong, Y., & Weiss, R. H. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00211.2002 · Cited by 13
Correction: Halocarbons produced by natural oxidation processes during degradation of organic matter
Keppler, F., Eiden, R., Niedan, V., Pracht, J., & Schöler, H. F. (2001) · Nature · doi:10.1038/35053144z · Cited by 13
Molecular and Cellular Function of p63 in Skin Development and Genetic Diseases
Girolamo, D. D., Iorio, E. D., & Missero, C. (2024) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2024.08.011 · Cited by 11
Kaneko, N., Kawano, S., Yasuda, K., Hashiguchi, Y., Sakamoto, T., Matsubara, R., Goto, Y., Jinno, T., Maruse, Y., Morioka, M., et al. (2017) · Oral Oncology · doi:10.1016/j.oraloncology.2017.11.004 · Cited by 12
Cheung, A., Tsun, K.-L., Ng, K.-M., Szeto, E. F., Siu, M. K. Y., Wong, E., & Ngan, H. (2010) · Modern Pathology · doi:10.1038/modpathol.2009.198 · Cited by 12
Maeso‐Alonso, L., López‐Ferreras, L., Marqués, M. M., & Marín, M. C. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.716957 · Cited by 12
The Molecular Basis of Lung Carcinogenesis
Fong, K. M., Sekido, Y., & Minna, J. D. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-125-1_17 · Cited by 12
Fonseca, M. B., Nunes, A. F., Morgado, A. L., Solá, S., & Rodrigues, C. M. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052417 · Cited by 12
UBE4B: A Promising Regulatory Molecule in Neuronal Death and Survival
Zeinab, R. A., Wu, H., Sergi, C. M., & Leng, R. P. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131216865 · Cited by 12
The p53 Tumour Suppressor Protein
Hickman, E. S., & Helin, K. (2000) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2000.10647992 · Cited by 12
p73, like its p53 homolog, shows preference for inverted repeats forming cruciforms
Čechová, J., Coufal, J., Jagelská, E. B., Fojta, M., & Brázda, V. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195835 · Cited by 12
L'atrésie folliculaire, un gaspillage programmé.
Monniaux, D., Mandon‐Pepin, B., & Monget, P. (1999) · médecine/sciences · doi:10.4267/10608/1306 · Cited by 12
The BAG-1 cochaperone is a negative regulator of p73-dependent transcription
Wang, X., O’Connor, D. J., Brimmell, M., & Packham, G. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604985 · Cited by 12
Domínguez, G., Silva, J., Silva, J. M., García, J. M. P., Larrondo, F. J., Vargas, J., Sanfrutos, L., Provencio, M., España, P., & Bonilla, F. (2001) · Genes Chromosomes and Cancer · doi:10.1002/gcc.1123 · Cited by 12
Chen, Y.-K., Hsue, S., & Lin, L. (2002) · Archives of Oral Biology · doi:10.1016/s0003-9969(02)00054-7 · Cited by 12
Cellular Mortality and Immortalization: A Complex Interplay of Multiple Gene Functions
Wadhwa, R., Kaul, S. C., & Mitsui, Y. (1999) · Progress in molecular and subcellular biology · doi:10.1007/978-3-662-06227-2_9 · Cited by 12
Kooti, A., Abuei, H., Farhadi, A., Behzad‐Behbahani, A., & Zarrabi, M. (2022) · Virus Genes · doi:10.1007/s11262-022-01887-8 · Cited by 10
Li, W., Wang, S. S., Deng, J., & Tang, J. X. (2017) · Oncology Letters · doi:10.3892/ol.2017.6327 · Cited by 10
Adeluola, A. A., Bosomtwe, N., Long, T. E., & Amin, A. R. M. R. (2022) · APOPTOSIS · doi:10.1007/s10495-022-01720-5 · Cited by 11
Rabow, Z., Laubach, K., Kong, X., Shen, T., Mohibi, S., Zhang, J., Fiehn, O., & Chen, X. (2022) · Cells · doi:10.3390/cells11162516 · Cited by 11
Zheng, L., Tang, W., Shi, Y., Chen, S., Wang, X., Wang, L., Shao, A., Ding, G., Liu, C., Liu, R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096958 · Cited by 11
Association Between the p73 Exon 2 G4C14-to-A4T14 Polymorphism and Cancer Risk: A Meta-Analysis
Hu, Y., Jiang, L., Zheng, J., You, Y., Zhou, Y., & Jiao, S. (2011) · DNA and Cell Biology · doi:10.1089/dna.2011.1305 · Cited by 11
Expression and clinical significance of TAp73α, p53, PCNA and apoptosis in hepatocellular carcinoma
Qin, H. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i18.2709 · Cited by 11
The Challenge of p53: Linking Biochemistry, Biology, and Patient Management
Bray, S. E., Schorl, C., & Hall, P. A. (1998) · Stem Cells · doi:10.1002/stem.160248 · Cited by 11
Miró‐Mur, F., Meiller, A., Haddada, H., & May, E. (2003) · Oncogene · doi:10.1038/sj.onc.1206538 · Cited by 11
p73 transcriptional activity increases upon cooperation between its spliced forms
Alarcon-Vargas, D., Fuchs, S. Y., Deb, S., & Ronai, Z. A. (2000) · Oncogene · doi:10.1038/sj.onc.1203311 · Cited by 11
Fine mapping of distal 1p loci reveals TP73 at D1S468
Perri, P., Praml, C., Savelyeva, L., Pillmann, A., & Schwab, M. (1999) · Cytogenetic and Genome Research · doi:10.1159/000015233 · Cited by 11
The yeast two-hybrid system reveals no interaction between p73α and SV40 large T-antigen
Reichelt, M., Zang, K. D., Seifert, M., Welter, C., & Ruffing, T. L. (1999) · Archives of Virology · doi:10.1007/s007050050530 · Cited by 11
Hu, J., Ulaner, G. A., Oruganti, H., Ivaturi, R. D., Balagura, K. A., Pham, J., Vu, T. H., & Hoffman, A. R. (2000) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(00)00017-8 · Cited by 11
Murine tumor suppressor models
Venkatachalam, S., & Donehower, L. A. (1998) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(98)00018-9 · Cited by 11
Lööf, J., Pfeifer, D., Adell, G., & Sun, X. (2009) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2009.06.007 · Cited by 10
Molecular pathology of retinoblastoma
Biswas, J., Kandalam, M., Mitra, M., & Subramanian, K. (2010) · Middle East African Journal of Ophthalmology · doi:10.4103/0974-9233.65498 · Cited by 10
Zhang, Z., Xiong, L., Lu, B.-T., Zhang, H.-X., Zhang, P., & Wang, T. (2017) · Cell Transplantation · doi:10.1177/0963689717716510 · Cited by 10
A narrative review for the Hippo-YAP pathway in cancer survival and immunity: the Yin-Yang dynamics
Wang, R., & Zhu, G. (2021) · Translational Cancer Research · doi:10.21037/tcr-21-1843 · Cited by 9
Uboveja, A., Satija, Y. K., Siraj, F., & Saluja, D. (2022) · iScience · doi:10.1016/j.isci.2022.103811 · Cited by 10
Garranzo‐Asensio, M., Rodríguez‐Cobos, J., Millán, C. S., Poves, C. F., Fernández‐Aceñero, M. J., Pastor‐Morate, D., Viñal, D., Montero‐Calle, A., Solís‐Fernández, G., Ceron, M., et al. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13228 · Cited by 10
Zhou, X., & Wu, C. (2012) · Medical Oncology · doi:10.1007/s12032-012-0240-x · Cited by 10
Application of array-comparative genomic hybridization in tetralogy of Fallot
Liu, L., Wang, H., Cui, C., Wu, D., Li, T., Fan, T., Peng, B., Zhang, L., & Wang, C. (2016) · Medicine · doi:10.1097/md.0000000000005552 · Cited by 10
Identification of a novel splicing form of zebrafish p73 having a strong transcriptional activity
Satoh, S., Arai, K., & Watanabe, S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.10.109 · Cited by 10
Sasaki, M., Oh, B. R., Dharia, A., Fujimoto, S., & Dahiya, R. (2000) · Molecular Carcinogenesis · doi:10.1002/1098-2744(200010)29:2 · Cited by 70
p73-dependent expression of DAN during cisplatin-induced cell death and osteoblast differentiation
Shinbo, J., Ozaki, T., Nakagawa, T., Watanabe, K., Nakamura, Y., Yamazaki, M., Moriya, H., Nakagawara, A., & Sakiyama, S. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00707-6 · Cited by 10
Rb Inhibits E2F-1-induced Cell Death in a LXCXE-dependent Manner by Active Repression
Pennaneach, V., Barbier, V., Regazzoni, K., Fotedar, R., & Fotedar, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309809200 · Cited by 10
Expression of p73 in Colorectal Carcinoma: Clinicopathological Relevance
Liu, L., Cui, X., Sakaguchi, T., Sasaki, M., Suda, T., & Hatakeyama, K. (2001) · Journal of International Medical Research · doi:10.1177/147323000102900406 · Cited by 10
Comparative proteomic analysis of Helicoverpa armigera cells undergoing apoptosis
Courtiade, J., Muck, A., Svatoš, A., Heckel, D. G., & Pauchet, Y. (2011) · Journal of Proteome Research · doi:10.1021/pr2001868 · Cited by 9
Heat treatment-induced functional and structural aspects of Mus musculus TAp63γ
Xu, Y., Wang, J.-Z., Li, J., Huang, X., Xing, Z.-H., & Du, L. (2011) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2011.03.064 · Cited by 9
Díaz, R., González‐Sancho, J. M., Soldevilla, B., Silva, J., García, J. M., García‐Barberán, V., Peña, C., Herrera, M., Gómez, I., Bonilla, F., et al. (2010) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20821 · Cited by 9
Laubach, K., Yan, W., Kong, X., Sun, W., Chen, M., Zhang, J., & Chen, X. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2123202119 · Cited by 9
Allelic expression and quantitative RT-PCR study of TAp73 and ΔNp73 in non-Hodgkin's lymphomas
Cuadros, M., Ribas, G., Fernández, V., Rivas, C., Benitez, J. J., & Martínez–Delgado, B. (2005) · Leukemia Research · doi:10.1016/j.leukres.2005.06.024 · Cited by 9
Lahortiga, I., V�zquez, I., Belloni, E., Rom�n, J. P., Gasparini, P., Novo, F. J., Zudaire, I., Pelicci, P. G., Hern�ndez, J. M., Calasanz, M. J., et al. (2005) · Human Genetics · doi:10.1007/s00439-005-1268-1 · Cited by 9
p53 and p73 in suppression of Myc‐driven lymphomagenesis
Griesmann, H., Schlereth, K., Krause, M., Samans, B., & Stiewe, T. (2008) · International Journal of Cancer · doi:10.1002/ijc.23978 · Cited by 9
Weiss, R. H., & Howard, L. L. (2001) · Cellular Signalling · doi:10.1016/s0898-6568(01)00195-4 · Cited by 9
Liao, J., Wen, S., Cao, L., Zhou, Y., & Feng, Z. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124576 · Cited by 9
Adámik, M., Bažantová, P., Navrátilová, L., Polášková, A., Pečínka, P., Holaňová, L., Tichý, V., & Brázdová, M. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.11.027 · Cited by 9
Alteration of p73 in acute myelogenous leukemia
Sahu, G. R., Mishra, R., Nagpal, J. K., & Das, B. R. (2005) · American Journal of Hematology · doi:10.1002/ajh.20284 · Cited by 9
RetractedStudy of the gonocyte cell cycle in irradiated TP53 knockout mouse foetuses and newborns
Moreno, S. G., Dutrillaux, B., & Coffigny, H. (2002) · International Journal of Radiation Biology · doi:10.1080/09553000210134818 · Cited by 9
Susumu, N., Aoki, D., Noda, T., Nagashima, Y., Hirao, T., Tamada, Y., Banno, K., Suzuki, A., Suzuki, N., Tsuda, H., et al. (2005) · International Journal of Gynecological Cancer · doi:10.1111/j.1048-891x.2005.14424.x · Cited by 9
Tumor Suppressor Gene Aberrations in Acute Myelogenous Leukemia
Stirewalt, D. L., & Radich, J. P. (2000) · Hematology · doi:10.1080/10245332.2000.11746484 · Cited by 9
Tumor suppressive role of the epigenetic master regulator BRD3 in colorectal cancer
Hashimoto, M., Masuda, T., Nakano, Y., Tobo, T., Saito, H., Koike, K., Takahashi, J., Abe, T., Ando, Y., Ozato, Y., et al. (2024) · Cancer Science · doi:10.1111/cas.16129 · Cited by 10
Hu, X., Wu, N., Xia, P., Yu, S., Sun, F., & Chen, J. (2012) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-012-1823-0 · Cited by 8
Hepatitis C virus in the etiology of hepatocellular carcinoma
Kiyosawa, K., & Tanaka, E. (2002) · Perspectives in medical virology · doi:10.1016/s0168-7069(02)06064-0 · Cited by 8
Hsp72 mediates TAp73α anti-apoptotic effects in small cell lung carcinoma cells
Nyman, U., Muppani, N. R., Zhivotovsky, B., & Joseph, B. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01166.x · Cited by 8
Li, F., Du, Z., Huang, X., Dong, C., & Ren, J. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.0c03521 · Cited by 9
p73 expression and its clinical significance in colorectal cancer
Su, X., Ouyang, X., Yan, M. ‐., & Liu, G. (2008) · Colorectal Disease · doi:10.1111/j.1463-1318.2008.01736.x · Cited by 8
Shao, A., Zheng, L., Chen, S., Gu, H., & Hua, J. (2014) · Biomarkers · doi:10.3109/1354750x.2014.996607 · Cited by 8
P53 and p73 differ in their ability to inhibit glucocorticoid receptor (GR) transcriptional activity
Zhang, L., Nie, L., & Maki, C. G. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-68 · Cited by 8
Chung, Y. H., & Kim, D. (2016) · Oncology Reports · doi:10.3892/or.2016.4895 · Cited by 8
McCarthy, N. J., Mercer, J. R., & Bennett, M. R. (2001) · Cardiology Clinics · doi:10.1016/s0733-8651(05)70196-x · Cited by 8
Morrison, R. S., & Kinoshita, Y. (2000) · Science · doi:10.1126/science.289.5477.257 · Cited by 8
Lo, W. D., Akhmametyeva, E. M., Zhu, L., Friesen, P. D., & Chang, L. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(03)00052-4 · Cited by 8
Expression of p63 and p73 in retinoblastoma: A clinicopathological correlation study
Mohan, A., Venkatesan, N., Kandalam, M., & Krishnakumar, S. (2008) · Experimental Eye Research · doi:10.1016/j.exer.2008.06.010 · Cited by 8
Tudzarova, S., & Węsierska‐Gądek, J. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10678 · Cited by 8
Knillová, J., & Kolář, Z. (2003) · Biomedical Papers · doi:10.5507/bp.2003.001 · Cited by 8
Vikhanskaya, F., & Broggini, M. (2002) · International review of cytology · doi:10.1016/s0074-7696(02)19013-9 · Cited by 8
Clinicopathological characteristics of breast carcinomas with allelic loss in the p73
Domínguez, G., Silva, J., Silva, J. M., Garcia, J. M., Miralles, C., Rodriguez, O. A., Jareño, E., Provencio, M., España, P., & Bonilla, F. (2000) · Breast Cancer Research and Treatment · doi:10.1023/a:1006446709715 · Cited by 8
Grob, T. J., Fey, M. F., & Tobler, A. (2002) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401018 · Cited by 8
Roberts, R. A. (1998) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(97)00239-x · Cited by 8
Lima, K., Carvalho, M. F. L., Pereira‐Martins, D. A., Nogueira, F. L., de Miranda, L. B. L., do Nascimento, M. C., Cavaglieri, R. D. C., Schuringa, J. J., Machado‐Neto, J. A., & Rego, E. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316899 · Cited by 7
Sahu, S. K., Mohanty, S., Kumar, A., Kundu, C. N., Verma, S. C., & Choudhuri, T. (2013) · Virology · doi:10.1016/j.virol.2013.10.023 · Cited by 7
Kim, H., Hong, M.-W., Bae, Y.-H., & Lee, S. (2021) · Archives of Industrial Hygiene and Toxicology · doi:10.2478/aiht-2021-72-3555 · Cited by 7
Tumor suppressive pathways in the control of neurogenesis
Bartesaghi, S., & Salomoni, P. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1063-9 · Cited by 8
Molecular Determinants of Intrinsic Multidrug Resistance in Cancer Cells and Tumors
Monti, E. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-035-5_14 · Cited by 7
Suppression of PKC causes oncogenic stress for triggering apoptosis in cancer cells
Ganapathy, S., Peng, B., Shen, L., Yu, T., Lafontant, J., Li, P., Xiong, R., Makriyannis, A., & Chen, C. (2017) · Oncotarget · doi:10.18632/oncotarget.16047 · Cited by 7
Alghamdi, R. M., Hassan, M., Kaleem, M., Kayali, A., Halwani, M., Zamzami, M. A., Choudhry, H., & Alhosin, M. (2020) · European Journal of Cell Science · doi:10.34154/2020-ejcs-0201-20-26/euraass · Cited by 7
Zeinab, R. A., Wu, H. H., Abuetabh, Y., Leng, S., Sergi, C. M., Eisenstat, D. D., & Leng, R. P. (2021) · Carcinogenesis · doi:10.1093/carcin/bgab009 · Cited by 6
Delta Np73 expression in thyroid neoplasms originating from follicular cells
Ito, Y., Uramoto, H., Funa, K., Yoshida, H., Jikuzono, T., Asahi, S., Higashiyama, T., Tomoda, C., Takamura, Y., Miya, A., et al. (2006) · Pathology · doi:10.1080/00313020600696298 · Cited by 7
Senoo, M., Matsumura, Y., & Habu, S. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5429 · Cited by 7
Inokuchi, K., Hamaguchi, H., Taniwaki, M., Yamaguchi, H., Tanosaki, S., & Dan, K. (2001) · Genes Chromosomes and Cancer · doi:10.1002/gcc.1181 · Cited by 7
Peña, C., Garcia, J. M., Domínguez, G., Silva, J., García‐Barberán, V., Carcereny, E., Vargas, J., Provencio, M., España, P., & Bonilla, F. (2004) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10322 · Cited by 7
Tumor suppressors: from genes to function and possible therapies
Helin, K., & Peters, G. G. (1998) · Trends in Genetics · doi:10.1016/s0168-9525(97)01341-3 · Cited by 7
Mechanisms of apoptosis regulation and antiapoptotic action of oncogenic viruses
Philchenkov, A. A., & Butenko, Z. A. (2000) · Biopolymers and Cell · doi:10.7124/bc.00058b · Cited by 7
Adenosine deaminase, not immune to a mechanistic rethink in central nervous system disorders?
Hall, B., George, J. G., & Allen, S. P. (2022) · PubMed · doi:10.14670/hh-18-404 · Cited by 7
Impact of p73 gene polymorphism on cancer susceptibility: a meta analysis.
Liu, Y., Dong, W., Mou, Q., Leng, Y., Zhang, L., & Duan, L. (2014) · PubMed Central · Cited by 6
Jahedi, H., Fahud, A. L., & Lim, C. L. (2019) · World Academy of Sciences Journal · doi:10.3892/wasj.2019.23 · Cited by 6
p53-Family Proteins in Odontogenic Cysts: An Immunohistochemical Study
Mascitti, M., Togni, L., Balercia, A., Balercia, P., Rubini, C., & Santarelli, A. (2018) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000727 · Cited by 6
Huqun, Endo, Y., Xin, H., Takahashi, M., Nukiwa, T., & Hagiwara, K. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01508.x · Cited by 6
Lee, S.-W., Kim, E.-J., & Um, S. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.128 · Cited by 6
Metadata
- Authors
- Jost, C. A., Marin, M. C., & Jr, W. G. K.
- Affiliations
- Harvard University (US)
- Venue
- Nature
- Published
- 1997-09-11
- Volume
- 389
- Issue
- 6647
- Pages
- 191-194
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1675096266
- Cited by
- 948
- References
- 25
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 13 · 2023: 7 · 2022: 15 · 2021: 18 · 2020: 13 · 2019: 13 · 2018: 11 · 2017: 15 · 2016: 18 · 2015: 20 · 2014: 19 · 2013: 25 · 2012: 26
- FWCI
- 34.25
- Type
- journal article
- Language
- en
- Update notices
- erratum (1999-06-24)
- Open access
- closed
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- p73, p53, tumor suppressor proteins, apoptosis, transcriptional activation, cell growth inhibition, neuroblastoma, chromosome 1p deletion, p21, programmed cell death
- MeSH terms
- Tumor Protein p73, Cell Division, Cell Line, Chromosome Mapping, Chromosomes, Human, Pair 1, DNA-Binding Proteins, Growth Inhibitors, Humans, Molecular Sequence Data, Neuroblastoma, Nuclear Proteins, Plasmids, Tumor Cells, Cultured, Chloramphenicol O-Acetyltransferase, Transcriptional Activation, Genes, Tumor Suppressor, Tumor Suppressor Protein p53, Cyclins, Mutagenesis, Site-Directed, Apoptosis, Tumor Suppressor Proteins, Cyclin-Dependent Kinase Inhibitor p21
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review